Wolfe Research Downgrades Regal Rexnord to Peer Perform

Wolfe Research analyst Nigel Coe downgrades Regal Rexnord (NYSE:RRX) from Outperform to Peer Perform.

Wolfe Research analyst Nigel Coe downgrades Regal Rexnord (NYSE:RRX) from Outperform to Peer Perform.

Total
0
Shares
Related Posts
Read More

Reported Late Tuesday April 11, Connect Biopharma Reports FY22 Financial Results And Provides Business Update; FY22 EPS $(2.10); Cash, Cash Equivalents, And Short-Term And Long-Term Investments Were $161.9M As Of December 31, 2022

2022 Financial Results Cash, cash equivalents, and short-term and long-term investments were RMB 1,127.3 million (USD 161.9 million) as of December 31, 2022, compared with RMB 1,706.9 million (USD 267.7 million) at

CNTB